Nausea and vomiting of pregnancy and hyperemesis gravidarum

MS Fejzo, J Trovik, IJ Grooten, K Sridharan… - Nature reviews Disease …, 2019 - nature.com
Nausea and vomiting of pregnancy (NVP) is a common condition that affects as many as
70% of pregnant women. Although no consensus definition is available for hyperemesis …

The biomarkers for acute myocardial infarction and heart failure

XY Wang, F Zhang, C Zhang… - BioMed research …, 2020 - Wiley Online Library
The use of a large number of cardiovascular biomarkers, meant to complement the use of
the electrocardiogram, echocardiography cardiac imaging, and clinical symptom …

Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum

MS Fejzo, OV Sazonova, JF Sathirapongsasuti… - Nature …, 2018 - nature.com
Hyperemesis gravidarum (HG), severe nausea and vomiting of pregnancy, occurs in 0.3–2%
of pregnancies and is associated with maternal and fetal morbidity. The cause of HG …

Nutrition Assessment and Dietary Interventions in Heart Failure: JACC Review Topic of the Week

E Driggin, LP Cohen, D Gallagher, W Karmally… - Journal of the American …, 2022 - jacc.org
Despite the high prevalence of nutrition disorders in patients with heart failure (HF), major
HF guidelines lack specific nutrition recommendations. Because of the lack of standardized …

Cardiac cachexia: hic et nunc

G Loncar, J Springer, M Anker… - Journal of cachexia …, 2016 - Wiley Online Library
Cardiac cachexia (CC) is the clinical entity at the end of the chronic natural course of heart
failure (HF). Despite the efforts, even the most recent definition of cardiac cachexia has been …

[HTML][HTML] Analysis of GDF15 and IGFBP7 in hyperemesis gravidarum support causality

MS Fejzo, PA Fasching, MO Schneider… - Geburtshilfe und …, 2019 - thieme-connect.com
Objective Hyperemesis gravidarum, severe nausea and vomiting in pregnancy, occurs in up
to 2% of pregnancies and leads to significant weight loss, dehydration, electrolyte …

[PDF][PDF] Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview

M Michalska-Kasiczak, A Bielecka-Dabrowa… - Archives of Medical …, 2018 - termedia.pl
The prevalence of heart failure with preserved ejection fraction (HFpEF) is steadily
increasing. Its diagnosis remains difficult and controversial and relies mostly on non …

[HTML][HTML] Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: results from TSOC-HFrEF registry

HY Chang, CC Wang, J Wei, CY Chang… - Journal of the Chinese …, 2017 - Elsevier
Background Heart failure (HF) is a global health problem. Guidelines for the management of
HF have been established in Western countries and in Taiwan. However, data from the …

Prognostic performance of serial in‐hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the …

HD Düngen, V Tscholl, D Obradovic… - ESC heart …, 2018 - Wiley Online Library
Aims In heart failure, various biomarkers are established for diagnosis and risk stratification;
however, little is known about the relevance of serial measurements during an episode …

Prognostic relevance of gradual weight changes on long-term mortality in chronic heart failure

T Täger, J Franke, N Frey, L Frankenstein… - Nutrition, Metabolism and …, 2023 - Elsevier
Background and aims While obesity has been linked to better ouctomes (the obesity
paradox), cachexia is associated with higher mortality in patients with heart failure with …